SCM
ZBH icon

Segantii Capital Management’s Zimmer Biomet ZBH Stock Holding History

Segantii Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-77,250
Closed -$8.95M – 79
2020
Q2 		$8.95M Buy
+77,250
New +$8.9M 0.63% 26

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Segantii Capital Management's ZBH Position: Q4 2016 in Review

Segantii Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 36,050 shares — an estimated $4.47M sold.

Segantii Capital Management first reported a position in ZBH in Q3 2016 and held it in 1 quarter. The position peaked at $4.47M in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • Segantii Capital Management reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
  • Segantii Capital Management sold 36,050 Zimmer Biomet shares in Q4 2016, an estimated $4.47M.
  • Segantii Capital Management first reported a position in Zimmer Biomet in Q3 2016 and held it in 1 quarter.
  • Segantii Capital Management's Zimmer Biomet position peaked at $4.47M in Q3 2016.
  • 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Segantii Capital Management's 13F filing for Q4 2016, filed 25 Jan 2017.